SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging as investors react to a significant Midjourney partnership and strong earnings, driving intense community debate over whether this reflects a long-term shift toward a semiconductor-led growth model or a classic hype-driven 'sell the news' trap. While optimistic retail traders highlight the company's proprietary ultrasound-on-chip technology as a major AI-driven catalyst, skeptics are actively warning against potential dilution and questioning the high valuation relative to current profitability.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is gaining significant market attention following a strategic memorandum of understanding with Supermicro to power AI data centers and the successful submission of a construction permit application for its Kronos microreactor. Community discourse is currently split between optimism regarding the stock's role in the AI-driven energy boom and concerns over its pre-revenue status and long-term regulatory hurdles.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is trending due to its lead role in the highly anticipated SpaceX IPO and broader institutional momentum as the bank hits all-time highs alongside other financial sector leaders. The community is actively discussing the firm's central involvement in major capital markets deals and its performance relative to broader banking benchmarks.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The semiconductor sector, anchored by the VanEck Semiconductor ETF, remains a focal point for investors as intense capital expenditure on AI infrastructure continues to fuel significant momentum. While the community is actively debating whether this represents a sustainable long-term boom or an overextended bubble, sentiment remains sharply divided between those chasing the persistent upward trend and those bracing for a potential liquidity-driven correction.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending due to the definitive merger agreement with Amazon, which offers shareholders $90 per share in a deal valued at over $11 billion. Community discussion is currently fixated on whether a higher unsolicited bid from competitors like SpaceX will emerge, alongside active debate regarding the valuation of the company's spectrum assets and the implications of the deal's structure.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye is trending as investors react to its new, vertically integrated Robotaxi business, which aims to challenge established players like Waymo and Uber with a U.S. deployment planned for 2027. While some members of the community express frustration over past delays and price volatility, others see the recent announcement and share repurchase program as major catalysts that could drive a significant rerating for the stock.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending as investors weigh recent positive catalystssuch as the resolved Publicis dispute, new leadership hires, and expanded partnershipsagainst ongoing concerns about its high short interest and underperformance. Community discussion is heavily divided, with some traders optimistic about a potential short squeeze at current valuation levels, while others criticize management and express frustration over the stock's persistent inability to sustain price momentum despite the steady flow of favorable news.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

The ProShares UltraPro QQQ is seeing high engagement as traders actively debate the sustainability of the AI-driven market rally and monitor volatility ahead of significant economic data and central bank updates. The community remains deeply divided, with bulls pointing to historical growth in major tech and semiconductor holdings while bears highlight mounting geopolitical risks and concerns over high valuations.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is trending as investors debate whether the asset's recent price decline represents a deep-value opportunity or a long-term failure, with community members aggressively divided over the protocol's future utility and market position. While bulls are highlighting the token's low circulating supply and potential for institutional adoption in the DeFi space, bears are actively pointing to the long-term price erosion as evidence of a structural breakdown.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Uranium Energy Corp is attracting significant attention as investors position for a structural energy supply squeeze, driven by the massive electricity demands of AI data centers and recent federal efforts to bolster domestic nuclear fuel infrastructure. The community remains focused on the company's unhedged production strategy and growing domestic output as a critical solution to long-term energy security.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Residential and Caesars Entertainment.read more...

HC Wainwright Issues Pessimistic Outlook for CBIO Earnings

Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) - Research analysts at HC Wainwright lowered their Q2 2026 earnings per share (EPS) estimates for shares of Crescent Biopharma in a note issued to investors on Monday, May 4th. HC Wainwright analyst M. Kapoor now forecasts that the biopharmaceutic...

Crescent Biopharma (NASDAQ:CBIO) Trading Up 8.3% - Here's Why

Crescent Biopharma (NASDAQ:CBIO) Stock Price Up 8.3% - Here's Why...

Crescent Biopharma (NASDAQ:CBIO) Shares Cross Above 200-Day Moving Average - Should You Sell?

Crescent Biopharma (NASDAQ:CBIO) Shares Cross Above 200-Day Moving Average - Should You Sell...

Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Analysts

Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) have earned an average recommendation of "Buy" from the nine research firms that are presently covering the firm, MarketBeat...

Crescent Biopharma (NASDAQ:CBIO) Shares Pass Above Two Hundred Day Moving Average - Here's What Happened

Crescent Biopharma (NASDAQ:CBIO) Stock Price Passes Above 200 Day Moving Average - What's Next...

Crescent Biopharma (NASDAQ:CBIO) Shares Pass Above 200-Day Moving Average - Time to Sell?

Crescent Biopharma (NASDAQ:CBIO) Share Price Passes Above 200 Day Moving Average - Should You Sell...

Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of "Buy" from Brokerages

Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) has earned a consensus rating of "Buy" from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have issued a buy rating and three h...

Crescent Biopharma (NASDAQ:CBIO) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded Crescent Biopharma from a "sell" rating to a "hold" rating in a research note on Saturday...

Crescent Biopharma (NASDAQ:CBIO) Price Target Lowered to $22.00 at HC Wainwright

HC Wainwright decreased their price target on shares of Crescent Biopharma from $25.00 to $22.00 and set a "buy" rating for the company in a research note on Monday...

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

Crescent Biopharma Inc.

The Deal That Sent Crescent Biopharma Shares Surging Over 40% Pre-Market Today

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

CBIOCrescent Biopharma Inc.

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest CBIO News